Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	833136	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	895675	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1067392	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1118992	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1152101	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1268631	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1329150	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1340319	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1388485	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1406741	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1409188	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1474161	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1491388	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1500467	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1507676	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1542043	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1554785	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1571892	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1580180	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1609039	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1611248	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1625900	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1643176	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1643377	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1660031	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1664077	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1682822	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1693127	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1697256	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1700551	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1701310	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1703378	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1706676	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1707831	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1708747	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1717679	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1727118	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1731708	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1732468	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1736201	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1762665	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1770893	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1773652	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1779690	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1831862	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1852414	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1863249	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1870059	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1882389	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1884973	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1888194	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1891250	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1909570	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1917843	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1924764	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1934100	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1939749	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1971420	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1986880	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	1998347	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2013312	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2019405	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2035106	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2046995	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2081635	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2082997	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2099294	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2158830	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2176309	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2184327	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2205025	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2222570	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2238866	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2244980	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2260766	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2266874	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2272316	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2324275	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2336918	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2342584	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2350063	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2361762	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2429917	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2466757	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2473228	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2483355	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2510914	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2525030	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2527033	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2531768	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2550393	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2552338	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2555548	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2648453	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2796276	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2812389	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	2974713	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	3187685	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	3297744	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	STEARATE (CAS# 57-11-4); (M-H)-	3311522	Peak area	Control	N	Letrozole	White	Baseline	Y	N